Compliance with hepatitis B and hepatitis C virus infection screening among HIV-1 infected patients in a resource-limited setting

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 39, Issue 5, 2008, Pages 867-875

  Sungkanuparph, Somnuek ^a,c   Wongprasit, Pawinee ^a   Manosuthi, Weerawat ^a,b   Atamasirikul, Kalayanee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MINISTRY OF PUBLIC HEALTH   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; FEMALE; HEALTH CARE ORGANIZATION; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MASS SCREENING; METHODOLOGY; ORGANIZATION AND MANAGEMENT; RISK FACTOR;

ADULT; ANTI-RETROVIRAL AGENTS; FEMALE; HEALTH CARE RATIONING; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MALE; MASS SCREENING; RISK FACTORS;

EID: 60249084223     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Alter MJ. Epidemiology of viral hepatitis and HIV coinfection. J Hepatol 2006; 44 (1 suppl): S6-9.
2. Bonacini M, Louie S, Bzowej N, Wohl AR. Survival in patients with HIV infection and viral hepatitis B or C: a cohort study. AIDS 2004; 18: 2039-45.
3. Cohen J. Thailand's do-it-yourself therapy. Science 2003;301:1662.
4. Chung DC, Ko YC, Chen CJ, Chen ER, Wu CC, Wu PS. Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan. J Med Virol 1989; 28: 215-8.
5. Gazzard B, Bernard AJ, Boffito M, et al. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006). HIV Med 2006; 7: 487-503.
6. Jongwutiwes U, Kiertiburanakul S, Sungkanuparph S. Impact of antiretroviral therapy on the relapse of cryptococcosis and survival of HIV-infected patients with cryptococcal infection. Curr HIV Res 2007; 5: 355-60.
7. Levy V, Grant RM. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls. Clin Infect Dis 2006; 43: 904-10.
8. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors of mortality among HIV/ tuberculosis-coinfected patients with and without antiretroviral therapy. J Acquir Immune Defic Syndr 2006; 43: 42-6.
9. Manosuthi W, Kiertiburanakul S, Chaovavanich A, Sungkanuparph S. Plasma nevirapine levels and 24-week efficacy of a fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) among Thai HIV-infected patients. J Med Assoc Thai 2007; 90: 244-50.
10. Ockenga J, Tillmann HL, Trautwein C, Stoll M, Manns MP, Schmidt RE. Hepatitis B and C in HIV-infected patients: prevalence and prognostic value. J Hepatol 1997; 27: 18-24.
11. Puoti M, Spinetti A, Ghezzi A, et al. Mortality for liver disease in patients with HIV infection: a cohort study. J Acquir Immune Defic Syndr 2000; 24: 211-7.
12. Rockstroh JK, Bhagani S, Benhamou Y, et al. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med 2008; 9: 82-8.
13. Roy E, Alary M, Morissette C, et al. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users, Int J STD AIDS 2007; 18: 23-7.
14. Sungkanuparph S, Vibhagool A, Manosuthi W, et al. Prevalence of hepatitis B and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study. J Med Assoc Thai 2004; 87: 1349-54.
15. Tin EE, Bowonwatanuwong C, Desakorn V, Wilairatana P, Krudsood S, Pitisuttithum R The efficacy and adverse effects of GPO-VIR (stavudine+lamivudine+nevirapine) in treatment-naive adult HIV patients. Southeast Asian J Trop Med Public Health 2005; 36: 362-9.
16. US Department of Health and Human Services (USDHHS) Panel on Antiretroviral Guidelines for Adults and Adolescents - A Working Group of the Office of AIDS Research Advisory Council (OARAC). Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. [Cited 2008 Jan 29]. Available from: URL: http://AIDSinfo.nih.gov
17. Weidle PJ, Malamba S, Mwebaze R, et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet 2002; 360: 34-40.
18. Zhou J, Dore GJ, Zhang F, Lim PL, Chen YM. TREAT Asia HIV Observational Database. Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database. J Gastroenterol Hepatol 2007; 22: 1510-8.